Cadence Pharmaceuticals To Present At The 7th Annual JMP Securities Healthcare Conference In New York City On July 12, 2012
SAN DIEGO, July 5, 2012 /PRNewswire/ — Cadence Pharmaceuticals, Inc. (NASDAQ: CADX), a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting, announced today that the company’s Chief Commercial Officer, Scott Byrd, will present the company’s corporate overview on Thursday, July 12, 2012 at 3:30pm Eastern Time (12:30pm Pacific Time) during the 7th Annual JMP Securities Healthcare Conference at the Peninsula New York Hotel in New York City.
The presentation will be simultaneously webcast and can be accessed on Cadence Pharmaceuticals’ website at www.cadencepharm.com in the Investors section. A replay of the webcast will be available approximately three hours following the live webcast and will be archived for 30 days.
About Cadence Pharmaceuticals, Inc.
Cadence Pharmaceuticals is a biopharmaceutical company focused on acquiring, in-licensing, developing and commercializing proprietary products principally for use in the hospital setting. The current version of Cadence Pharmaceuticals’ corporate overview may be viewed on the “Investors” page of www.cadencepharm.com under “Events and Presentations.”
Contacts: William R. LaRue SVP, CFO Cadence Pharmaceuticals, Inc. 858-436-1400
SOURCE Cadence Pharmaceuticals, Inc.